A. Volynkina

Therapy of obesity by sibutramin: polymorphisms of TPH2 and GNB3 genes and decrease of body weight

A. S. Pavlova, E. Troshina, M. Galieva, 2018, Obesity and metabolism.

The effect of combined melatonin therapy on indicators of oxidative status in chronic kidney disease developing in type 2 diabetes mellitus

K. Shulgin, A. Pashkov, A. Verevkin, 2021, Clinical Medicine (Russian Journal).

The role of genetic factors in predicting results of obesity treatment with sibutramine – serotonin-norepinephrine reuptake inhibitor

A. S. Pavlova, E. Troshina, M. Galieva, 2016 .

Obesity

E. Andreeva, Y. Yashkov, E. Troshina, 2021, Consilium Medicum.

NARUShENIE METABOLIZMA KOSTNOY TKANI U PATsIENTOV S NARUShENIYaMI FUNKTsII ShchITOVIDNOY ZhELEZY

T. Chernykh, A. Volynkina, A. Zakharchenko, 2016 .

[Experience of successful laparoscopic sleeve resection of the stomach and treatment of morbid obesity in a patient with a classic form of congenital adrenal dysfunction].

A. Volynkina, А. В. Степаненко, С. Самойлов, 2023, Problemy endokrinologii.